Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals’ supplemental application for Bupropion Hydrochloride (SR). The approval updates the labeling for the s…
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals …
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for a generic bupropion hydrochloride product by Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., establishing a generic sustained-release f…
-
FDA approval · 2025-11-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)
FDA approved a supplemental application for bupropion hydrochloride from CIPLA USA INC., under the generic drug approval pathway.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-05FDA Approved: AUVELITY — Supplemental Application (Axsome Therapeutics, Inc.)
The FDA approved a supplemental application for AUVELITY, the fixed-dose combination of dextromethorphan hydrobromide and bupropion hydrochl…
-
FDA approval · 2025-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, approving a new generic form of the antid…
-
FDA approval · 2025-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Bupropion Hydrochloride from BluePoint Laboratories. This action updates the approved generi…
-
EMA approval · 2025-10-31EMA Authorised: Zurzuvae (zuranolone) — Biogen Netherlands B.V.
The EMA authorised Zurzuvae (zuranolone) by Biogen Netherlands B.V. for depression and postpartum depression.
-
FDA approval · 2025-10-22FDA Approved: ARIPIPRAZOLE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved the original application for aripiprazole from Quagen Pharmaceuticals LLC, marking the availability of a generic aripiprazole p…
-
EMA approval · 2025-10-15EMA Authorised: Duloxetine Viatris (previously Duloxetine Mylan) (duloxetine) — Viatris Limited
The European Medicines Agency authorised a duloxetine product marketed as Duloxetine Viatris by Viatris Limited for several indications incl…
-
FDA approval · 2025-10-09FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
The FDA approved a supplemental application for SPRAVATO (esketamine hydrochloride) filed by Janssen Pharmaceuticals Inc.
-
FDA approval · 2025-10-09FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, authorizing its marketin…
-
FDA approval · 2025-10-06FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Micro Labs Limited.
-
FDA approval · 2025-10-02FDA Approved: MIRTAZAPINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic form of mirtazapine (Camber Pharmaceuticals) via Original Application.
-
FDA approval · 2025-10-01FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original-application for generic bupropion hydrochloride, authorizing a new generic entry of the antide…
-
FDA approval · 2025-09-29FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for desipramine hydrochloride from Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-09-26FDA Approved: FLUOXETINE — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approves a supplemental application for fluoxetine hydrochloride from NIVAGEN Pharmaceuticals, enabling the marketing of a generic fluox…
-
FDA approval · 2025-09-24FDA Approved: PAROXETINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc. Paroxetine Original Application for a generic paroxetine product.
-
FDA approval · 2025-09-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC under an ANDA.
-
FDA approval · 2025-09-12FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA granted a supplemental approval for a generic quetiapine fumarate product from Hikma Pharmaceuticals USA Inc. (ANDA 090749). The approva…
-
EMA approval · 2025-09-10EMA Authorised: Spravato (esketamine hydrochloride) — Janssen-Cilag International NV
The EMA authorised Spravato (esketamine hydrochloride) for depressive disorders, with Janssen-Cilag International NV as the marketing author…
-
FDA approval · 2025-09-04FDA Approved: SELEGILINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Selegiline Hydrochloride from Chartwell RX, LLC, enabling the generic product's approval.
-
FDA approval · 2025-09-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for a generic venlafaxine hydrochloride product.
-
FDA approval · 2025-08-29FDA Approved: ESCITALOPRAM — Original Application (Almatica Pharma LLC)
FDA approved the original application for escitalopram from Almatica Pharma LLC, making a generic escitalopram available. The approval cover…